Cargando…
Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer
BACKGROUND: The aim of this exploratory subgroup analysis of the fluorouracil, oxaliplatin, docetaxel (FLOT)65+ trial was to determine tolerability and feasibility of perioperative chemotherapy in elderly, potentially operable esophagogastric cancer patients. METHODS: Patients aged ⩾65 with locally...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593547/ https://www.ncbi.nlm.nih.gov/pubmed/23322206 http://dx.doi.org/10.1038/bjc.2012.588 |
_version_ | 1782262264588402688 |
---|---|
author | Lorenzen, S Pauligk, C Homann, N Schmalenberg, H Jäger, E Al-Batran, S-E |
author_facet | Lorenzen, S Pauligk, C Homann, N Schmalenberg, H Jäger, E Al-Batran, S-E |
author_sort | Lorenzen, S |
collection | PubMed |
description | BACKGROUND: The aim of this exploratory subgroup analysis of the fluorouracil, oxaliplatin, docetaxel (FLOT)65+ trial was to determine tolerability and feasibility of perioperative chemotherapy in elderly, potentially operable esophagogastric cancer patients. METHODS: Patients aged ⩾65 with locally advanced esophagogastric adenocarcinoma were randomized to perioperative chemotherapy consisting of four pre- and four postoperative cycles of infusional 5-FU, leucovorin, and oxaliplatin (FLO) without or with docetaxel 50 mg m(−)(2) (FLOT), every 2 weeks. RESULTS: Forty-four patients with a median age of 70 years were randomized and 43 patients started preoperative chemotherapy (FLO, 22; FLOT, 21). Thirty-eight (86.4%) patients completed four cycles of preoperative chemotherapy and 32 (74.4%) proceeded to surgery, with 67.4% R0 resections on intent-to-treat analysis (90.1% of the 32 patients who underwent resection). Median overall survival was not reached and median progression-free survival (PFS) was 17.3 months. Compared with the FLO group, the FLOT group showed a trend towards an improved median PFS (21.1 vs 12.0 months; P=0.09), however, associated with increased chemotherapy related toxicity. No perioperative mortality was observed. Postoperative morbidity was observed in 46.9% of patients (FLO, 35.3% FLOT, 60%). CONCLUSION: Neoadjuvant FLO or FLOT may offer a reasonable chance of curative surgery in elderly patients with locally advanced resectable gastroesophageal cancer. However, the increase in side effects with the FLOT regimen and postoperative morbidity should be carefully considered when an intensive chemotherapy regimen is planned. |
format | Online Article Text |
id | pubmed-3593547 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-35935472014-02-19 Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer Lorenzen, S Pauligk, C Homann, N Schmalenberg, H Jäger, E Al-Batran, S-E Br J Cancer Clinical Study BACKGROUND: The aim of this exploratory subgroup analysis of the fluorouracil, oxaliplatin, docetaxel (FLOT)65+ trial was to determine tolerability and feasibility of perioperative chemotherapy in elderly, potentially operable esophagogastric cancer patients. METHODS: Patients aged ⩾65 with locally advanced esophagogastric adenocarcinoma were randomized to perioperative chemotherapy consisting of four pre- and four postoperative cycles of infusional 5-FU, leucovorin, and oxaliplatin (FLO) without or with docetaxel 50 mg m(−)(2) (FLOT), every 2 weeks. RESULTS: Forty-four patients with a median age of 70 years were randomized and 43 patients started preoperative chemotherapy (FLO, 22; FLOT, 21). Thirty-eight (86.4%) patients completed four cycles of preoperative chemotherapy and 32 (74.4%) proceeded to surgery, with 67.4% R0 resections on intent-to-treat analysis (90.1% of the 32 patients who underwent resection). Median overall survival was not reached and median progression-free survival (PFS) was 17.3 months. Compared with the FLO group, the FLOT group showed a trend towards an improved median PFS (21.1 vs 12.0 months; P=0.09), however, associated with increased chemotherapy related toxicity. No perioperative mortality was observed. Postoperative morbidity was observed in 46.9% of patients (FLO, 35.3% FLOT, 60%). CONCLUSION: Neoadjuvant FLO or FLOT may offer a reasonable chance of curative surgery in elderly patients with locally advanced resectable gastroesophageal cancer. However, the increase in side effects with the FLOT regimen and postoperative morbidity should be carefully considered when an intensive chemotherapy regimen is planned. Nature Publishing Group 2013-02-19 2013-01-15 /pmc/articles/PMC3593547/ /pubmed/23322206 http://dx.doi.org/10.1038/bjc.2012.588 Text en Copyright © 2013 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/3.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ |
spellingShingle | Clinical Study Lorenzen, S Pauligk, C Homann, N Schmalenberg, H Jäger, E Al-Batran, S-E Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer |
title | Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer |
title_full | Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer |
title_fullStr | Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer |
title_full_unstemmed | Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer |
title_short | Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer |
title_sort | feasibility of perioperative chemotherapy with infusional 5-fu, leucovorin, and oxaliplatin with (flot) or without (flo) docetaxel in elderly patients with locally advanced esophagogastric cancer |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593547/ https://www.ncbi.nlm.nih.gov/pubmed/23322206 http://dx.doi.org/10.1038/bjc.2012.588 |
work_keys_str_mv | AT lorenzens feasibilityofperioperativechemotherapywithinfusional5fuleucovorinandoxaliplatinwithflotorwithoutflodocetaxelinelderlypatientswithlocallyadvancedesophagogastriccancer AT pauligkc feasibilityofperioperativechemotherapywithinfusional5fuleucovorinandoxaliplatinwithflotorwithoutflodocetaxelinelderlypatientswithlocallyadvancedesophagogastriccancer AT homannn feasibilityofperioperativechemotherapywithinfusional5fuleucovorinandoxaliplatinwithflotorwithoutflodocetaxelinelderlypatientswithlocallyadvancedesophagogastriccancer AT schmalenbergh feasibilityofperioperativechemotherapywithinfusional5fuleucovorinandoxaliplatinwithflotorwithoutflodocetaxelinelderlypatientswithlocallyadvancedesophagogastriccancer AT jagere feasibilityofperioperativechemotherapywithinfusional5fuleucovorinandoxaliplatinwithflotorwithoutflodocetaxelinelderlypatientswithlocallyadvancedesophagogastriccancer AT albatranse feasibilityofperioperativechemotherapywithinfusional5fuleucovorinandoxaliplatinwithflotorwithoutflodocetaxelinelderlypatientswithlocallyadvancedesophagogastriccancer |